Article Information
vol. 13 no. 576
- Received for publication April 8, 2020
- Resubmitted August 6, 2020
- Accepted for publication December 11, 2020
- .
Author Information
- E. Lake Potter1,
- Hannah P. Gideon2,
- Victor Tkachev3,4,
- Giulia Fabozzi1,
- Alexander Chassiakos1,
- Constantinos Petrovas1,
- Patricia A. Darrah1,
- Philana Ling Lin5,
- Kathryn E. Foulds1,
- Leslie S. Kean3,4,
- JoAnne L. Flynn2 and
- Mario Roederer1,*
- 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- 2Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
- 3Boston Children’s Hospital, Division of Hematology/Oncology, Boston, MA 02115, USA.
- 4Dana-Farber Cancer Institute, Department of Pediatric Oncology and Harvard Medical School, Boston, MA 02215, USA.
- 5Department of Pediatrics, University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
- ↵*Corresponding author. Email: roederer{at}nih.gov